Fact CheckerSign in

NCT06752967Completed

Hormonal Control of Energy and Macronutrient Intake in Obesity (MEMORY)

Hormonal Control of Energy and Macronutrient Intake in Obesity

Source: ClinicalTrials.gov · Last updated 19 Aug 2026

Brief summary (registry, in English)

The overall aim of the MEMORY study is to examine the concept of 'food memory' - how specific macronutrient compositions influence subsequent food preference and intake, and whether this differs across the BMI range from normal weight to obesity.

Status (registry)
Completed
Study type
Interventional
Enrollment
47 (actual)
First submitted
5 Nov 2024
Start date
12 Dec 2024
Primary completion date
25 Jun 2026
Lead sponsor
Steno Diabetes Center Copenhagen
Diseases
Obesity
NCT number
NCT06752967

What you commit to

  • Study type: Interventional
  • Participants enrolled: 47
  • From 12 Dec 2024 to the primary completion date, 25 Jun 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Self-reported weight change (kg) within two months prior to inclusion
  • Treatment with antidepressants
  • Alcohol/drug abuse or in treatment with disulfiram (antabus) at time of inclusion
  • Current treatment with medication which significantly affect appetite or energy balance (e.g., GLP-1 receptor agonists)
  • Bariatric surgery
  • Concomitant participation in intervention studies

Other illness

  • Not able or willing to eat or drink the test meals because of e.g., allergy or intolerance
  • Self-reported history of an eating disorder
  • Uncontrolled medical issues including but not limited to cardiovascular pulmonary, rheumatologic, hematologic, oncologic, infectious, gastrointestinal, or psychiatric disease; diabetes or other endocrine disease; immunosuppression

Lab values

  • HbA1c ≥48 mmol/mol

Other

  • Daily smoking
  • For women: Pregnancy / planned pregnancy (within the study period) / lactating
  • Unable to understand the informed consent and the study procedures
  • Participant's withdrawal of the informed consent
  • Other safety concerns - judged by the investigator

Who the study is looking for

  • Age 18-45 years
  • For women: Regular menstruation
  • BMI-range 18.5-39.9 kg/m\^2

Age in the registry: 18 years to 45 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Steno Diabetes Center Copenhagen
Coordinator of this site? Confirm its status
HerlevDenmarkUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.